Howe & Rusling Inc Repligen Corp Transaction History

Howe & Rusling Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $16,587 - $22,095	-100 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $9,018 - $11,313	-50 Reduced 33.33%	100 $19,000
Q4 2020 Feb 08, 2021	BUY	$148.08 - $206.57 $12,586 - $17,558	85 Added 130.77%	150 $29,000
Q2 2020 Jul 15, 2020	BUY	$94.33 - $140.48 $2,641 - $3,933	28 Added 75.68%	65 $8,000
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $3,143 - $4,038	37 New	37 $4,000

522

53.2M

1.05M

228K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.66B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.